Skip to content
Trial Eligibility
Menu

Acellular Dermal Matrix Investigation in Breast Reconstruction

NCT06456554

This study is recruiting at 12 US sites in 10 states, according to its ClinicalTrials.gov record last updated .

Summary

Prospective, multi-center, dual-arm non-randomized clinical study in females undergoing a two-stage breast reconstruction using a pre-pectoral technique.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Breast Reconstruction

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
22 years and older
Sex
Female
Healthy volunteers
Accepted
Sponsor
RTI Surgical
Last updated on ClinicalTrials.gov
April 30, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Arkansas · 1

  • University of Arkansas · Little Rock, AR

California · 1

  • City of Hope National Medical Center · Duarte, CA

Colorado · 1

  • University of Colorado · Aurora, CO

Kansas · 1

  • University of Kansas · Lawrence, KS

Missouri · 2

  • Mercy Hospital · St Louis, MO
  • Washington University · St Louis, MO

New York · 2

  • New York Presbyterian Hospital/Columbia University Irving Medical Center · New York, NY
  • NYU Langone Health · New York, NY

Ohio · 1

  • Cleveland Clinic · Cleveland, OH

Oklahoma · 1

  • Mercy · Oklahoma City, OK

Pennsylvania · 1

  • University of Pennsylvania · Philadelphia, PA

Texas · 1

  • MD Anderson · Houston, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.